Cardiac Arrhythmia Service, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
J Am Geriatr Soc. 2013 Oct;61(10):1798-803. doi: 10.1111/jgs.12456. Epub 2013 Sep 19.
Atrial fibrillation (AF) is a common and morbid cardiac arrhythmia that increases in prevalence with advancing age. The risk of ischemic stroke, a primary and disabling hazard of AF, also increases with advancing age. The aging of the population is anticipated to contribute to a rising burden of AF-related morbidity and economic costs, given the close association between the arrhythmia and aging. Recent biological, diagnostic, and therapeutic developments raise hope that AF-related stroke can be largely prevented, yet despite advances in stroke prevention for individuals with AF, numerous scientific and clinical knowledge gaps remain, particularly as these developments are applied to older adults. Given the public health importance of AF-related stroke in elderly adults, a group of clinician-investigators convened on April 5, 2012, to identify promising areas for investigation that may ultimately reduce stroke-related morbidity. This article summarizes the meeting discussion and emphasizes innovative topic areas that may ultimately facilitate the application of novel preventive, diagnostic, and therapeutic insights into the management of older adults with AF. The opinions of those that participated in the meeting limit this report, which may not represent all of the questions that other experts in this field might raise.
心房颤动(AF)是一种常见且严重的心律失常,其发病率随年龄增长而增加。随着年龄的增长,AF 引起的缺血性中风的风险也会增加,而中风是 AF 的主要致残危险因素。鉴于心律失常与衰老之间存在密切关联,预计人口老龄化将导致与 AF 相关的发病率和经济成本负担增加。最近在生物学、诊断和治疗方面的进展带来了希望,即可以在很大程度上预防 AF 相关的中风,但尽管在预防 AF 个体的中风方面取得了进展,仍然存在许多科学和临床知识空白,尤其是在将这些进展应用于老年人时。鉴于 AF 相关中风对老年人的公共卫生重要性,一组临床研究人员于 2012 年 4 月 5 日召开会议,确定了有希望的研究领域,这些领域可能最终会降低中风相关的发病率。本文总结了会议讨论,并强调了创新的主题领域,这些领域最终可能有助于将新型预防、诊断和治疗方法应用于管理老年 AF 患者。参加会议的人员的意见局限了本报告,本报告可能无法代表该领域其他专家可能提出的所有问题。